Global and Japan Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2026

Publisher Name :
Date: 11-Sep-2020
No. of pages: 128
Inquire Before Buying

Pneumococcal Polysaccharide Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Pneumococcal Polysaccharide Vaccine market is segmented into

- Single Dose Vial

- Pre-Filled Syringe

Segment by Application, the Pneumococcal Polysaccharide Vaccine market is segmented into

- Children (2-10 Age)

- Adult (10-64 Age)

- Geriatric (More Than 65 Age)

Regional and Country-level Analysis

The Pneumococcal Polysaccharide Vaccine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Pneumococcal Polysaccharide Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pneumococcal Polysaccharide Vaccine Market Share Analysis

Pneumococcal Polysaccharide Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumococcal Polysaccharide Vaccine business, the date to enter into the Pneumococcal Polysaccharide Vaccine market, Pneumococcal Polysaccharide Vaccine product introduction, recent developments, etc.

The major vendors covered:

- Merck & Co., Inc.

- Pfizer Inc.

- Glaxosmithkline Plc.

- Sanofi Pasteur

- China National Biotec Group

- Astellas Pharma Inc

- Serum Institute of India Pvt. Ltd

- MSD

Global and Japan Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pneumococcal Polysaccharide Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pneumococcal Polysaccharide Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type
1.4.2 Single Dose Vial
1.4.3 Pre-Filled Syringe
1.5 Market by Application
1.5.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application
1.5.2 Children (2-10 Age)
1.5.3 Adult (10-64 Age)
1.5.4 Geriatric (More Than 65 Age)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Polysaccharide Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2015-2026
2.1.2 Global Pneumococcal Polysaccharide Vaccine Sales 2015-2026
2.2 Global Pneumococcal Polysaccharide Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pneumococcal Polysaccharide Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026)
3 Global Pneumococcal Polysaccharide Vaccine Competitor Landscape by Players
3.1 Global Top Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue
3.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pneumococcal Polysaccharide Vaccine Revenue in 2019
3.2.5 Global Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pneumococcal Polysaccharide Vaccine Price by Manufacturers
3.4 Global Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Polysaccharide Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2015-2020)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020)
4.1.3 Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pneumococcal Polysaccharide Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2015-2020)
5.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2015-2020)
5.1.3 Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
5.2 Pneumococcal Polysaccharide Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
6.1.1 Japan Pneumococcal Polysaccharide Vaccine Sales YoY Growth 2015-2026
6.1.2 Japan Pneumococcal Polysaccharide Vaccine Revenue YoY Growth 2015-2026
6.1.3 Japan Pneumococcal Polysaccharide Vaccine Market Share in Global Market 2015-2026
6.2 Japan Pneumococcal Polysaccharide Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Pneumococcal Polysaccharide Vaccine Players by Sales (2015-2020)
6.2.2 Japan Top Pneumococcal Polysaccharide Vaccine Players by Revenue (2015-2020)
6.3 Japan Pneumococcal Polysaccharide Vaccine Historic Market Review by Type (2015-2020)
6.3.1 Japan Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
6.3.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 Japan Pneumococcal Polysaccharide Vaccine Price by Type (2015-2020)
6.4 Japan Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026)
6.4.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 Japan Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2021-2026)
6.5 Japan Pneumococcal Polysaccharide Vaccine Historic Market Review by Application (2015-2020)
6.5.1 Japan Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
6.5.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 Japan Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
6.6 Japan Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026)
6.6.2 Japan Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 Japan Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
7.2 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
7.2.1 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020)
7.2.2 North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
8.2.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Country
8.2.2 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country
10.2.2 Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country
11.2.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck & Co., Inc.
12.1.1 Merck & Co., Inc. Corporation Information
12.1.2 Merck & Co., Inc. Description and Business Overview
12.1.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Products Offered
12.1.5 Merck & Co., Inc. Recent Development
12.2 Pfizer Inc.
12.2.1 Pfizer Inc. Corporation Information
12.2.2 Pfizer Inc. Description and Business Overview
12.2.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Products Offered
12.2.5 Pfizer Inc. Recent Development
12.3 Glaxosmithkline Plc.
12.3.1 Glaxosmithkline Plc. Corporation Information
12.3.2 Glaxosmithkline Plc. Description and Business Overview
12.3.3 Glaxosmithkline Plc. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Products Offered
12.3.5 Glaxosmithkline Plc. Recent Development
12.4 Sanofi Pasteur
12.4.1 Sanofi Pasteur Corporation Information
12.4.2 Sanofi Pasteur Description and Business Overview
12.4.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Products Offered
12.4.5 Sanofi Pasteur Recent Development
12.5 China National Biotec Group
12.5.1 China National Biotec Group Corporation Information
12.5.2 China National Biotec Group Description and Business Overview
12.5.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
12.5.4 China National Biotec Group Pneumococcal Polysaccharide Vaccine Products Offered
12.5.5 China National Biotec Group Recent Development
12.6 Astellas Pharma Inc
12.6.1 Astellas Pharma Inc Corporation Information
12.6.2 Astellas Pharma Inc Description and Business Overview
12.6.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Products Offered
12.6.5 Astellas Pharma Inc Recent Development
12.7 Serum Institute of India Pvt. Ltd
12.7.1 Serum Institute of India Pvt. Ltd Corporation Information
12.7.2 Serum Institute of India Pvt. Ltd Description and Business Overview
12.7.3 Serum Institute of India Pvt. Ltd Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Products Offered
12.7.5 Serum Institute of India Pvt. Ltd Recent Development
12.8 MSD
12.8.1 MSD Corporation Information
12.8.2 MSD Description and Business Overview
12.8.3 MSD Sales, Revenue and Gross Margin (2015-2020)
12.8.4 MSD Pneumococcal Polysaccharide Vaccine Products Offered
12.8.5 MSD Recent Development
12.11 Merck & Co., Inc.
12.11.1 Merck & Co., Inc. Corporation Information
12.11.2 Merck & Co., Inc. Description and Business Overview
12.11.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Products Offered
12.11.5 Merck & Co., Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pneumococcal Polysaccharide Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Polysaccharide Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pneumococcal Polysaccharide Vaccine Market Segments
Table 2. Ranking of Global Top Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Single Dose Vial
Table 5. Major Manufacturers of Pre-Filled Syringe
Table 6. Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Pneumococcal Polysaccharide Vaccine Sales by Regions 2015-2020 (K Units)
Table 9. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Pneumococcal Polysaccharide Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Polysaccharide Vaccine as of 2019)
Table 16. Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pneumococcal Polysaccharide Vaccine Price (2015-2020) (USD/Unit)
Table 19. Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pneumococcal Polysaccharide Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2015-2020) (K Units)
Table 24. Global Pneumococcal Polysaccharide Vaccine Sales Share by Type (2015-2020)
Table 25. Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2015-2020)
Table 27. Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2026)
Table 29. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2015-2020) (K Units)
Table 30. Global Pneumococcal Polysaccharide Vaccine Sales Share by Application (2015-2020)
Table 31. Global Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2026)
Table 32. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Pneumococcal Polysaccharide Vaccine Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Pneumococcal Polysaccharide Vaccine Sales Share by Company (2015-2020)
Table 37. Japan Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2015-2020)
Table 39. Japan Pneumococcal Polysaccharide Vaccine Sales Share by Type (2015-2020)
Table 40. Japan Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Pneumococcal Polysaccharide Vaccine Price (K Units) by Type (2015-2020)
Table 42. Japan Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2021-2026)
Table 43. Japan Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2026)
Table 44. Japan Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2026)
Table 46. Japan Pneumococcal Polysaccharide Vaccine Price (K Units) by Type (2021-2026)
Table 47. Japan Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2015-2020)
Table 48. Japan Pneumococcal Polysaccharide Vaccine Sales Share by Application (2015-2020)
Table 49. Japan Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2021-2026)
Table 51. Japan Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2026)
Table 52. Japan Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2026)
Table 54. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 55. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 56. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 59. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 60. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
Table 66. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 67. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 74. Merck & Co., Inc. Corporation Information
Table 75. Merck & Co., Inc. Description and Business Overview
Table 76. Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Product
Table 78. Merck & Co., Inc. Recent Development
Table 79. Pfizer Inc. Corporation Information
Table 80. Pfizer Inc. Description and Business Overview
Table 81. Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Pfizer Inc. Product
Table 83. Pfizer Inc. Recent Development
Table 84. Glaxosmithkline Plc. Corporation Information
Table 85. Glaxosmithkline Plc. Description and Business Overview
Table 86. Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Glaxosmithkline Plc. Product
Table 88. Glaxosmithkline Plc. Recent Development
Table 89. Sanofi Pasteur Corporation Information
Table 90. Sanofi Pasteur Description and Business Overview
Table 91. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Sanofi Pasteur Product
Table 93. Sanofi Pasteur Recent Development
Table 94. China National Biotec Group Corporation Information
Table 95. China National Biotec Group Description and Business Overview
Table 96. China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. China National Biotec Group Product
Table 98. China National Biotec Group Recent Development
Table 99. Astellas Pharma Inc Corporation Information
Table 100. Astellas Pharma Inc Description and Business Overview
Table 101. Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Astellas Pharma Inc Product
Table 103. Astellas Pharma Inc Recent Development
Table 104. Serum Institute of India Pvt. Ltd Corporation Information
Table 105. Serum Institute of India Pvt. Ltd Description and Business Overview
Table 106. Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Serum Institute of India Pvt. Ltd Product
Table 108. Serum Institute of India Pvt. Ltd Recent Development
Table 109. MSD Corporation Information
Table 110. MSD Description and Business Overview
Table 111. MSD Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. MSD Product
Table 113. MSD Recent Development
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Pneumococcal Polysaccharide Vaccine Players
Table 118. Pneumococcal Polysaccharide Vaccine Customers List
Table 119. Pneumococcal Polysaccharide Vaccine Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-Filled Syringe Product Picture
Figure 5. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Children (2-10 Age)
Figure 7. Adult (10-64 Age)
Figure 8. Geriatric (More Than 65 Age)
Figure 9. Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 10. Global Pneumococcal Polysaccharide Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Pneumococcal Polysaccharide Vaccine Sales 2015-2026 (K Units)
Figure 12. Global Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2019
Figure 15. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Pneumococcal Polysaccharide Vaccine Revenue in 2019
Figure 19. Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 22. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Pneumococcal Polysaccharide Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 27. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2019
Figure 29. Japan Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2015-2026 (K Units)
Figure 30. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. Japan Pneumococcal Polysaccharide Vaccine Market Share in Global Market 2015-2026
Figure 32. Japan 5 and 10 Largest Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in Pneumococcal Polysaccharide Vaccine in 2019
Figure 33. Japan Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2015-2020)
Figure 34. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Japan Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2015-2020)
Figure 36. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2019
Figure 40. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2019
Figure 41. U.S. Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2019
Figure 48. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2019
Figure 49. Germany Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2019
Figure 63. China Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2019
Figure 88. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2019
Figure 89. Mexico Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argen
  • COVID-19 World Encephalitis Vaccination Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 14-Oct-2020        Price: US 2800 Onwards        Pages: 106
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Encephalitis Vaccination , covering Glob......
  • Global and United States Meningococcal Conjugate Market Size, Status and Forecast 2020-2026
    Published: 14-Oct-2020        Price: US 3900 Onwards        Pages: 97
    Global Meningococcal Conjugate Scope and Market Size Meningococcal Conjugate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product c......
  • COVID-19 World 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 12-Oct-2020        Price: US 2800 Onwards        Pages: 97
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for 23-Valent Pneumococcal Polysaccharide Va......
  • Global and China Encephalitis Vaccine Market Insights, Forecast to 2026
    Published: 06-Oct-2020        Price: US 3900 Onwards        Pages: 125
    Encephalitis Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Encephalitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Encephalitis Vaccine market is ......
  • (COVID-19 Version) Global Meningococcal Vaccines Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 01-Oct-2020        Price: US 3000 Onwards        Pages: 108
    Summary The report forecast global Meningococcal Vaccines market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Meningococcal Vaccines industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Meningococcal Vaccines......
  • Global and China H1N1 Vaccines Market Insights, Forecast to 2026
    Published: 30-Sep-2020        Price: US 3900 Onwards        Pages: 127
    H1N1 Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global H1N1 Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the H1N1 Vaccines market is segmented into ......
  • (COVID-19 Version) Global Influenza Vaccine Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 28-Sep-2020        Price: US 3000 Onwards        Pages: 107
    Summary The report forecast global Influenza Vaccine market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Influenza Vaccine industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Influenza Vaccine by geography. ......
  • (Post-pandemic Era) - Global Meningococcal Vaccines Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 24-Sep-2020        Price: US 3210 Onwards        Pages: 81
    Summary As the world continues to deal with COVID-19, economies are moving into recession, official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. On a more positive note, we are already seeing signs of recovery as the COVID-19 risk is declining in China. Chinese original equipment manufactur......
  • (Post-pandemic Era) - Global Meningococcal Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 24-Sep-2020        Price: US 3620 Onwards        Pages: 102
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs